Combination therapy boosts antiviral response to chronic infection

A Yale-led team has identified a promising new combination immunotherapy to enhance the body’s ability to fight chronic viral infections and possibly cancer.

Paxlovid enhances treatment options for COVID-19 patients

Diagram of combination therapy. Dual therapy is defined as the

Omicron and the Immunocompromised: How to Stay Safe

Medical Xpress - medical research advances and health news

Animal data supports efficacy of baricitinib vs SARS-COV-2

Medical Xpress - medical research advances and health news

Core Concepts - Antiretroviral Medications and Initial Therapy

Therapeutic advances in COVID-19

Research Tools for Long COVID Syndrome